{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:08:15Z","timestamp":1781734095153,"version":"3.54.5"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although deep brain stimulation (DBS) has been proven to enhance motor function in Parkinson\u2019s disease (PD) patients, its potential adverse impact on cognitive function remains ambiguous. This study aimed to explore the effects of DBS on cognitive function in patients with advanced PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PubMed, EBSCO, Cochrane Library, Web of Science, and Embase were searched for randomized controlled trials (RCTs) and cohort studies on DBS and advanced PD from inception to January 2025. The main cognitive function assessment tools include but are not limited to Mini-MENTAL State Examination (MMSE) and Mattis Dementia Rating Scale (MDRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 7 RCTs and 11 cohort studies were included. Analyses reveals no significant differences in MMSE (mean difference [MD] = \u22120.33,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.19) and MDRS (MD = \u22120.75,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.08) between the DBS group and the best medical therapy (BMT) group overall. However, the DBS group had significantly worse cognitive function after treatment than the BMT group in phonemic fluency (MD = \u22123.17,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03). No significant differences were observed between the groups in other domains, including information processing, memory, executive function, and visuospatial function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DBS poses a potential risk to cognitive function in patients with advanced PD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/med-2025-1292","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:56:58Z","timestamp":1760032618000},"source":"Crossref","is-referenced-by-count":1,"title":["A meta-analysis of the effects of DBS on cognitive function in patients with advanced PD"],"prefix":"10.1515","volume":"20","author":[{"given":"Yuxin","family":"Gai","sequence":"first","affiliation":[{"name":"Department of Neurology , Ningbo Yinzhou No. 2 Hospital , Ningbo , 315100, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyi","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Lin","sequence":"additional","affiliation":[{"name":"School of Medicine, Shaoxing University , Shaoxing , Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hujie","family":"Zhan","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Zhejiang University of Technology , Hangzhou , Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhui","family":"Fan","sequence":"additional","affiliation":[{"name":"The Second Clinical Medical College, Zhejiang Chinese Medical University , Hangzhou , Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Neurology , Ningbo Yinzhou No. 2 Hospital, 998 North Qianhe Road, Yinzhou District , Ningbo , 315100, Zhejiang , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2025122201305057465_j_med-2025-1292_ref_001","doi-asserted-by":"crossref","unstructured":"Hayes MT. Parkinson\u2019s disease and parkinsonism. Am J Med. 2019;132(7):802\u20137.","DOI":"10.1016\/j.amjmed.2019.03.001"},{"key":"2025122201305057465_j_med-2025-1292_ref_002","doi-asserted-by":"crossref","unstructured":"Elsworth JD. Parkinson\u2019s disease treatment: past, present, and future. J Neural Transm. 2020;127(5):785\u201391.","DOI":"10.1007\/s00702-020-02167-1"},{"key":"2025122201305057465_j_med-2025-1292_ref_003","doi-asserted-by":"crossref","unstructured":"Beudel M, Brown P. Adaptive deep brain stimulation in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):S123\u20136.","DOI":"10.1016\/j.parkreldis.2015.09.028"},{"key":"2025122201305057465_j_med-2025-1292_ref_004","doi-asserted-by":"crossref","unstructured":"Marsili L, Bologna M, Miyasaki JM, Colosimo C. Parkinson\u2019s disease advanced therapies \u2013 a systematic review: more unanswered questions than guidance. Parkinsonism Relat Disord. 2021;83:132\u20139.","DOI":"10.1016\/j.parkreldis.2020.10.042"},{"key":"2025122201305057465_j_med-2025-1292_ref_005","doi-asserted-by":"crossref","unstructured":"Limousin P, Foltynie T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol. 2019;15(4):234\u201342.","DOI":"10.1038\/s41582-019-0145-9"},{"key":"2025122201305057465_j_med-2025-1292_ref_006","doi-asserted-by":"crossref","unstructured":"Hong J, Xie H, Chen Y, Liu D, Wang T, Xiong K, et al. Effects of STN-DBS on cognition and mood in young-onset Parkinson\u2019s disease: a two-year follow-up. Front Aging Neurosci. 2023;15:1177889.","DOI":"10.3389\/fnagi.2023.1177889"},{"key":"2025122201305057465_j_med-2025-1292_ref_007","doi-asserted-by":"crossref","unstructured":"Acera M, Molano A, Tijero B, Bilbao G, Lambarri I, Villoria R, et al. Long-term impact of subthalamic stimulation on cognitive function in patients with advanced Parkinson\u2019s disease. Neurologia. 2019;34(9):573\u201381.","DOI":"10.1016\/j.nrleng.2017.05.008"},{"key":"2025122201305057465_j_med-2025-1292_ref_008","doi-asserted-by":"crossref","unstructured":"Hitti FL, Ramayya AG, McShane BJ, Yang AI, Vaughan KA, Baltuch GH. Long-term outcomes following deep brain stimulation for Parkinson\u2019s disease. J Neurosurg. 2020;132(1):205\u201310.","DOI":"10.3171\/2018.8.JNS182081"},{"key":"2025122201305057465_j_med-2025-1292_ref_009","doi-asserted-by":"crossref","unstructured":"Yu P, Wang Y, Su F, Chen Y. Comparing [18F]FET PET and [18F]FDOPA PET for glioma recurrence diagnosis: a systematic review and meta-analysis. Front Oncol. 2023;13:1346951.","DOI":"10.3389\/fonc.2023.1346951"},{"key":"2025122201305057465_j_med-2025-1292_ref_010","doi-asserted-by":"crossref","unstructured":"Just H, Ostergaard K. Health-related quality of life in patients with advanced Parkinson\u2019s disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord. 2002;17(3):539\u201345.","DOI":"10.1002\/mds.10111"},{"key":"2025122201305057465_j_med-2025-1292_ref_011","doi-asserted-by":"crossref","unstructured":"Cilia R, Siri C, Marotta G, De Gaspari D, Landi A, Mariani CB, et al. Brain networks underlining verbal fluency decline during STN-DBS in Parkinson\u2019s disease: an ECD-SPECT study. Parkinsonism Relat Disord. 2007;13(5):290\u20134.","DOI":"10.1016\/j.parkreldis.2006.11.011"},{"key":"2025122201305057465_j_med-2025-1292_ref_012","doi-asserted-by":"crossref","unstructured":"Merola A, Zibetti M, Angrisano S, Rizzi L, Lanotte M, Lopiano L. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson\u2019s disease. Mov Disord. 2011;26(4):664\u201370.","DOI":"10.1002\/mds.23524"},{"key":"2025122201305057465_j_med-2025-1292_ref_013","doi-asserted-by":"crossref","unstructured":"Mikos A, Zahodne L, Okun MS, Foote K, Bowers D. Cognitive declines after unilateral deep brain stimulation surgery in Parkinson\u2019s disease: a controlled study using reliable change, part II. Clin Neuropsychol. 2010;24(2):235\u201345.","DOI":"10.1080\/13854040903277297"},{"key":"2025122201305057465_j_med-2025-1292_ref_014","doi-asserted-by":"crossref","unstructured":"Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van Laar T, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study. Neurology. 2006;66(12):1830\u20136.","DOI":"10.1212\/01.wnl.0000234881.77830.66"},{"key":"2025122201305057465_j_med-2025-1292_ref_015","doi-asserted-by":"crossref","unstructured":"Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks Jr WJ, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63\u201373.","DOI":"10.1001\/jama.2008.929"},{"key":"2025122201305057465_j_med-2025-1292_ref_016","doi-asserted-by":"crossref","unstructured":"Williams A, Gill S, Varma T, Jenkinson C, Quinn N, Mitchell R, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson\u2019s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 2010;9(6):581\u201391.","DOI":"10.1016\/S1474-4422(10)70093-4"},{"key":"2025122201305057465_j_med-2025-1292_ref_017","doi-asserted-by":"crossref","unstructured":"Witt K, Daniels C, Reiff J, Krack P, Volkmann J, Pinsker MO, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson\u2019s disease: a randomised, multicentre study. Lancet Neurol. 2008;7(7):605\u201314.","DOI":"10.1016\/S1474-4422(08)70114-5"},{"key":"2025122201305057465_j_med-2025-1292_ref_018","doi-asserted-by":"crossref","unstructured":"York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, et al. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2008;79(7):789\u201395.","DOI":"10.1136\/jnnp.2007.118786"},{"key":"2025122201305057465_j_med-2025-1292_ref_019","doi-asserted-by":"crossref","unstructured":"Zahodne LB, Okun MS, Foote KD, Fernandez HH, Rodriguez RL, Kirsch-Darrow L, et al. Cognitive declines one year after unilateral deep brain stimulation surgery in Parkinson\u2019s disease: a controlled study using reliable change. Clin Neuropsychol. 2009;23(3):385\u2013405.","DOI":"10.1080\/13854040802360582"},{"key":"2025122201305057465_j_med-2025-1292_ref_020","doi-asserted-by":"crossref","unstructured":"Zangaglia R, Pacchetti C, Pasotti C, Mancini F, Servello D, Sinforiani E, et al. Deep brain stimulation and cognitive functions in Parkinson\u2019s disease: a three-year controlled study. Mov Disord. 2009;24(11):1621\u20138.","DOI":"10.1002\/mds.22603"},{"key":"2025122201305057465_j_med-2025-1292_ref_021","doi-asserted-by":"crossref","unstructured":"Blomstedt P, Stenmark Persson R, Hariz GM, Linder J, Fredricks A, H\u00e4ggstr\u00f6m B, et al. Deep brain stimulation in the caudal zona incerta versus best medical treatment in patients with Parkinson\u2019s disease: a randomised blinded evaluation. J Neurol Neurosurg Psychiatry. 2018;89(7):710\u20136.","DOI":"10.1136\/jnnp-2017-317219"},{"key":"2025122201305057465_j_med-2025-1292_ref_022","doi-asserted-by":"crossref","unstructured":"Charles D, Konrad PE, Neimat JS, Molinari AL, Tramontana MG, Finder SG, et al. Subthalamic nucleus deep brain stimulation in early stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2014;20(7):731\u20137.","DOI":"10.1016\/j.parkreldis.2014.03.019"},{"key":"2025122201305057465_j_med-2025-1292_ref_023","doi-asserted-by":"crossref","unstructured":"Hacker ML, Tramontana MG, Pazira K, Meystedt JC, Turchan M, Harper KA, et al. Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson\u2019s disease. Parkinsonism Relat Disord. 2023;113:105479.","DOI":"10.1016\/j.parkreldis.2023.105479"},{"key":"2025122201305057465_j_med-2025-1292_ref_024","doi-asserted-by":"crossref","unstructured":"Merola A, Rizzi L, Zibetti M, Artusi CA, Montanaro E, Angrisano S, et al. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson\u2019s disease: a different long-term outcome? J Neurol Neurosurg Psychiatry. 2014;85(5):552\u20139.","DOI":"10.1136\/jnnp-2013-305271"},{"key":"2025122201305057465_j_med-2025-1292_ref_025","doi-asserted-by":"crossref","unstructured":"Tramontana MG, Molinari AL, Konrad PE, Davis TL, Wylie SA, Neimat JS, et al. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson\u2019s disease in a randomized clinical trial. J Parkinsons Dis. 2015;5(1):151\u201363.","DOI":"10.3233\/JPD-140448"},{"key":"2025122201305057465_j_med-2025-1292_ref_026","doi-asserted-by":"crossref","unstructured":"Williams AE, Arzola GM, Strutt AM, Simpson R, Jankovic J, York MK. Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation. Parkinsonism Relat Disord. 2011;17(5):321\u20137.","DOI":"10.1016\/j.parkreldis.2011.01.011"},{"key":"2025122201305057465_j_med-2025-1292_ref_027","doi-asserted-by":"crossref","unstructured":"Witt K, Granert O, Daniels C, Volkmann J, Falk D, van Eimeren T, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson\u2019s disease: results from a randomized trial. Brain. 2013;136(Pt 7):2109\u201319.","DOI":"10.1093\/brain\/awt151"},{"key":"2025122201305057465_j_med-2025-1292_ref_028","doi-asserted-by":"crossref","unstructured":"Vijiaratnam N, Simuni T, Bandmann O, Morris HR, Foltynie T. Progress towards therapies for disease modification in Parkinson\u2019s disease. Lancet Neurol. 2021;20(7):559\u201372.","DOI":"10.1016\/S1474-4422(21)00061-2"},{"key":"2025122201305057465_j_med-2025-1292_ref_029","doi-asserted-by":"crossref","unstructured":"Dharnipragada R, Denduluri LS, Naik A, Bertogliat M, Awad M, Ikramuddin S, et al. Frequency settings of subthalamic nucleus DBS for Parkinson\u2019s disease: a systematic review and network meta-analysis. Parkinsonism Relat Disord. 2023;116:105809.","DOI":"10.1016\/j.parkreldis.2023.105809"},{"key":"2025122201305057465_j_med-2025-1292_ref_030","doi-asserted-by":"crossref","unstructured":"Jin K, Chen B, Han S, Dong J, Cheng S, Qin B, et al. Repetitive transcranial magnetic stimulation (rTMS) improves cognitive impairment and intestinal microecological dysfunction induced by high-fat diet in rats. Research. 2024;7:0384.","DOI":"10.34133\/research.0384"},{"key":"2025122201305057465_j_med-2025-1292_ref_031","doi-asserted-by":"crossref","unstructured":"Wang SS, Mao XF, Cai ZS, Lin W, Liu XX, Luo B, et al. Distinct olfactory bulb-cortex neural circuits coordinate cognitive function in parkinson\u2019s disease. Research. 2024;7:0484.","DOI":"10.34133\/research.0484"},{"key":"2025122201305057465_j_med-2025-1292_ref_032","doi-asserted-by":"crossref","unstructured":"Zheng W, Lv G, Lu Y, Liu J, Hao Q, Ding H, et al. Bilateral pallidal deep brain stimulation in meige syndrome: effects on motor function, neuropsychological status, and mood. Neurosurgery. 2023;92(5):1073\u20139.","DOI":"10.1227\/neu.0000000000002335"},{"key":"2025122201305057465_j_med-2025-1292_ref_033","doi-asserted-by":"crossref","unstructured":"Pal GD, Corcos DM, Metman LV, Israel Z, Bergman H, Arkadir D. Cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson\u2019s disease with GBA1 pathogenic variants. Mov Disord. 2023;38(12):2155\u201362.","DOI":"10.1002\/mds.29647"},{"key":"2025122201305057465_j_med-2025-1292_ref_034","doi-asserted-by":"crossref","unstructured":"Whitestone J, Salih A, Goswami T. Investigation of a deep brain stimulator (DBS) system. Bioengineering. 2023;10(10):1160.","DOI":"10.3390\/bioengineering10101160"},{"key":"2025122201305057465_j_med-2025-1292_ref_035","doi-asserted-by":"crossref","unstructured":"Damrongthai C, Kuwamizu R, Suwabe K, Ochi G, Yamazaki Y, Fukuie T, et al. Benefit of human moderate running boosting mood and executive function coinciding with bilateral prefrontal activation. Sci Rep. 2021;11(1):22657.","DOI":"10.1038\/s41598-021-01654-z"},{"key":"2025122201305057465_j_med-2025-1292_ref_036","doi-asserted-by":"crossref","unstructured":"Bachmann D, Buchmann A, Studer S, Saake A, Rauen K, Zuber I, et al. Age-, sex-, and pathology-related variability in brain structure and cognition. Transl Psychiatry. 2023;13(1):278.","DOI":"10.1038\/s41398-023-02572-6"},{"key":"2025122201305057465_j_med-2025-1292_ref_037","doi-asserted-by":"crossref","unstructured":"Yu Y, Wu K, Yang X, Long J, Chang C. Terahertz photons improve cognitive functions in posttraumatic stress disorder. Research. 2023;6:0278.","DOI":"10.34133\/research.0278"},{"key":"2025122201305057465_j_med-2025-1292_ref_038","doi-asserted-by":"crossref","unstructured":"van den Boom BJG, Elhazaz-Fernandez A, Rasmussen PA, van Beest EH, Parthasarathy A, Denys D, et al. Unraveling the mechanisms of deep-brain stimulation of the internal capsule in a mouse model. Nat Commun. 2023;14(1):5385.","DOI":"10.1038\/s41467-023-41026-x"},{"key":"2025122201305057465_j_med-2025-1292_ref_039","doi-asserted-by":"crossref","unstructured":"Neumann WJ, Steiner LA, Milosevic L. Neurophysiological mechanisms of deep brain stimulation across spatiotemporal resolutions. Brain. 2023;146(11):4456\u201368.","DOI":"10.1093\/brain\/awad239"},{"key":"2025122201305057465_j_med-2025-1292_ref_040","doi-asserted-by":"crossref","unstructured":"Hong J, Choi K, Fuccillo MV, Chung S, Weber F. Infralimbic activity during REM sleep facilitates fear extinction memory. Curr Biol. 2024;34(10):2247\u201355.e5.","DOI":"10.1016\/j.cub.2024.04.018"},{"key":"2025122201305057465_j_med-2025-1292_ref_041","doi-asserted-by":"crossref","unstructured":"Weinkle LJ, Hoyt B, Thompson JA, Sillau S, Tanabe J, Honce J, et al. Association of MRI measurements with cognitive outcomes after STN-DBS in Parkinson\u2019s disease. Mov Disord Clin Pract. 2018;5(4):417\u201326.","DOI":"10.1002\/mdc3.12643"},{"key":"2025122201305057465_j_med-2025-1292_ref_042","doi-asserted-by":"crossref","unstructured":"Tremblay P, Dick AS. Broca and Wernicke are dead, or moving past the classic model of language neurobiology. Brain Lang. 2016;162:60\u201371.","DOI":"10.1016\/j.bandl.2016.08.004"},{"key":"2025122201305057465_j_med-2025-1292_ref_043","doi-asserted-by":"crossref","unstructured":"Whelan BM, Murdoch BE, Theodoros DG, Silburn P, Hall B. Beyond verbal fluency: investigating the long-term effects of bilateral subthalamic (STN) deep brain stimulation (DBS) on language function in two cases. Neurocase. 2005;11(2):93\u2013102.","DOI":"10.1080\/13554790590925501"},{"key":"2025122201305057465_j_med-2025-1292_ref_044","doi-asserted-by":"crossref","unstructured":"Chiu SY, Tsuboi T, Hegland KW, Herndon NE, Shukla AW, Patterson A, et al. Dysarthria and speech intelligibility following Parkinson\u2019s disease globus pallidus internus deep brain stimulation. J Parkinsons Dis. 2020;10(4):1493\u2013502.","DOI":"10.3233\/JPD-202246"},{"key":"2025122201305057465_j_med-2025-1292_ref_045","doi-asserted-by":"crossref","unstructured":"Pedrosa DJ, Auth M, Pauls KA, Runge M, Maarouf M, Fink GR, et al. Verbal fluency in essential tremor patients: the effects of deep brain stimulation. Brain Stimul. 2014;7(3):359\u201364.","DOI":"10.1016\/j.brs.2014.02.012"},{"key":"2025122201305057465_j_med-2025-1292_ref_046","doi-asserted-by":"crossref","unstructured":"Tabari F, Berger JI, Flouty O, Copeland B, Greenlee JD, Johari K. Speech, voice, and language outcomes following deep brain stimulation: a systematic review. PLoS One. 2024;19(5):e0302739.","DOI":"10.1371\/journal.pone.0302739"},{"key":"2025122201305057465_j_med-2025-1292_ref_047","doi-asserted-by":"crossref","unstructured":"Tang V, Zhu CX, Chan D, Lau C, Chan A, Mok V, et al. Evidence of improved immediate verbal memory and diminished category fluency following STN-DBS in Chinese-Cantonese patients with idiopathic Parkinson\u2019s disease. Neurol Sci. 2015;36(8):1371\u20137.","DOI":"10.1007\/s10072-015-2117-1"},{"key":"2025122201305057465_j_med-2025-1292_ref_048","doi-asserted-by":"crossref","unstructured":"Hariz M, Blomstedt P. Deep brain stimulation for Parkinson\u2019s disease. J Intern Med. 2022;292(5):764\u201378.","DOI":"10.1111\/joim.13541"},{"key":"2025122201305057465_j_med-2025-1292_ref_049","doi-asserted-by":"crossref","unstructured":"Witt K, Daniels C, Volkmann J. Factors associated with neuropsychiatric side effects after STN-DBS in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18(Suppl 1):S168\u201370.","DOI":"10.1016\/S1353-8020(11)70052-9"},{"key":"2025122201305057465_j_med-2025-1292_ref_050","doi-asserted-by":"crossref","unstructured":"Luo B, Zou Y, Yan J, Sun J, Wei X, Chang L, et al. Altered cognitive networks connectivity in parkinson\u2019s disease during the microlesion period after deep brain stimulation. CNS Neurosci Ther. 2024;30(12):e70184.","DOI":"10.1111\/cns.70184"},{"key":"2025122201305057465_j_med-2025-1292_ref_051","doi-asserted-by":"crossref","unstructured":"Mosley PE, Akram H. Neuropsychiatric effects of subthalamic deep brain stimulation. Handb Clin Neurol. 2021;180:417\u201331.","DOI":"10.1016\/B978-0-12-820107-7.00026-4"},{"key":"2025122201305057465_j_med-2025-1292_ref_052","doi-asserted-by":"crossref","unstructured":"Olaciregui Dague K, Witt JA, von Wrede R, Helmstaedter C, Surges R. DBS of the ANT for refractory epilepsy: a single center experience of seizure reduction, side effects and neuropsychological outcomes. Front Neurol. 2023;14:1106511.","DOI":"10.3389\/fneur.2023.1106511"}],"container-title":["Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1292\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1292\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T01:42:15Z","timestamp":1766367735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/med-2025-1292\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,20]]},"published-print":{"date-parts":[[2025,1,20]]}},"alternative-id":["10.1515\/med-2025-1292"],"URL":"https:\/\/doi.org\/10.1515\/med-2025-1292","relation":{},"ISSN":["2391-5463"],"issn-type":[{"value":"2391-5463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]},"article-number":"20251292"}}